exhibition icon
register now icon
conference icon
get brochure icon
sponsors icon
add event to diary icon
email this to... icon
Safety assured
our speakers
Speaker photo
Susan Graver
Group Director -  Global Pharmacovigilance and Epidemiology
Bristol-Myers Squibb
Speaker photo
Prof Philippe Van der Auwera
Global Head of Safety Risk Management and EU-QPPV
F-Hoffman La Roche
Speaker photo
Dr Beverley Forsythe
Principal Safety Physician R&D, Clinical Development, Patient Safety
AstraZeneca
Speaker photo
Dr Larry Johnson
Executive Director, Global Safety Head of Therapeutic Area Safety
Amgen
conference details
Conference:
Pre-conference workshop
14 Sept 9am - 5pm
Day 1
15 Sept 8am - 5:30pm
Day 2
16 Sept 8am - 5:30pm
Post-conference workshop
17 Sept 9am - 5pm
 
Location: London, United Kingdom
› Email a friend
› Add this to my calendar
Register online now 
 
Contact LIVE
Drive your safety strategy forward
The 4th annual World Drug Safety Congress Europe conference brings together top pharmaceutical, biotechnology and regulatory representatives in a forum that addresses the key issues of the industry. 

For drug safety professionals
Health Network Communications would like to announce the 4th annual World Drug Safety Congress 2010, taking place 14 - 17 September in London, United Kingdom.

Making and fulfilling the right safety procedures is vitally important in today’s pharmaceutical industry and imperative to ensuring the successful long term future of a drug. At World Drug Safety Congress Europe you will find yourself amongst industry decision makers and thought leaders in this unique discussion forum.

» Get my quote
» Reserve your seat now


Revolutionise your drug safety strategy

The content
The in-depth drug safety conference programme covers the detection, analysis and prevention of adverse drug reactions with case studies and industry experiences as well as global regulatory coverage of developments in the US, Japan, Europe, Asia/Pacific, South America and Canada.

Key topics include Emerging Market Focus, International Regulatory Roundup, Risk Management & Communication, Benefit Risk Decision Making, Signal Reporting & Management, Clinical Safety Strategy, Safety in Early Development and Observational Studies/Post Approval Safety.

» More about the conference
» Download the brochure

The speakers
At World Drug Safety Congress Europe you can expect to see speakers from a wide range of countries. There will be case study updates, and we will strive to introduce fresh strategy content as we continue to keep track of the latest developments.

We have representation from Bristol-Myers Squibb, F-Hoffman La Roche, AstraZeneca, Amgen, Abbott, Eisai, Pfizer, Novartis and many more...

 

» Become a speaker
» Download the brochure

register for drug safety today
The people that matter to your business - drug safety professionals
This conference will be attended by directors, heads and managers working in the pharmaceutical industry in the following departments:
  • Pharmacovigilance
  • Drug Safety
  • Risk management and surveillance
  • Qualified person
  • Medical affairs
  • Quality specialist
  • Clinical safety
  • Chief Scientific Officer
  • Chief Medical Officer
  • Regulatory Affairs
  • Research and development
  • Chief Executive Officer
  • Managing Director
  • Drug Manufacturing

» Networking opportunities

 

 
event sponsors
Stream facilitator:
 

 

comment / report a mistake | contact us | about Terrapinn | site map | privacy | T&Cs a terrapin ©Terrapinn Holdings Ltd. MMX